Warning: The NCBI web site requires JavaScript to function. more...
Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.
Yan B, Yang X, Lee TL, Friedman J, Tang J, Van Waes C, Chen Z.
Genome Biol. 2007;8(5):R78.
Related citations
A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status.
Lee TL, Yang XP, Yan B, Friedman J, Duggal P, Bagain L, Dong G, Yeh NT, Wang J, Zhou J, Elkahloun A, Van Waes C, Chen Z.
Clin Cancer Res. 2007 Oct 1;13(19):5680-91.
Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status.
Yan B, Chen G, Saigal K, Yang X, Jensen ST, Van Waes C, Stoeckert CJ, Chen Z.
Genome Biol. 2008;9(3):R53. Epub 2008 Mar 11.
Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.
Ondrey FG, Dong G, Sunwoo J, Chen Z, Wolf JS, Crowl-Bancroft CV, Mukaida N, Van Waes C.
Mol Carcinog. 1999 Oct;26(2):119-29.
A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT, Van Waes C, Chen Z.
Int J Cancer. 2008 May 1;122(9):1987-98.
Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
Dong G, Loukinova E, Chen Z, Gangi L, Chanturita TI, Liu ET, Van Waes C.
Cancer Res. 2001 Jun 15;61(12):4797-808.
Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
Cohen J, Chen Z, Lu SL, Yang XP, Arun P, Ehsanian R, Brown MS, Lu H, Yan B, Diallo O, Wang XJ, Van Waes C.
Cancer Res. 2009 Apr 15;69(8):3415-24. Epub 2009 Apr 7.
Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van Waes C.
Cancer Res. 2004 Sep 15;64(18):6511-23. Erratum in: Cancer Res. 2004 Nov 1;64(21):8130-2.
cDNA microarray and bioinformatic analysis of nuclear factor-kappaB related genes in squamous cell carcinoma.
Chen Z, Lee TL, Yang XP, Dong G, Loercher A, Van Waes C.
Methods Mol Biol. 2007;383:81-99.
NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
Ferris RL, Grandis JR.
Clin Cancer Res. 2007 Oct 1;13(19):5663-4. Review. No abstract available.
IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.
Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N, Van Waes C.
Clin Cancer Res. 2001 Jun;7(6):1812-20.
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG.
Cancer Res. 2006 Aug 15;66(16):8210-8.
Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.
Allen C, Saigal K, Nottingham L, Arun P, Chen Z, Van Waes C.
Clin Cancer Res. 2008 Jul 1;14(13):4175-85.
Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z.
Cancer Res. 2005 Aug 15;65(16):7071-80.
ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.
Yang X, Lu H, Yan B, Romano RA, Bian Y, Friedman J, Duggal P, Allen C, Chuang R, Ehsanian R, Si H, Sinha S, Van Waes C, Chen Z.
Cancer Res. 2011 May 15;71(10):3688-700. Erratum in: Cancer Res. 2011 Dec 1;71(23):7323.
A TNF-induced gene expression program under oscillatory NF-kappaB control.
Tian B, Nowak DE, Brasier AR.
BMC Genomics. 2005 Sep 28;6:137.
Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM.
Clin Cancer Res. 2008 Jan 15;14(2):366-9.
Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma.
Chen Z, Zhang K, Zhang X, Yuan XH, Yuan Z, Jin L, Xiong M.
Clin Exp Metastasis. 2003;20(4):335-42.
Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma.
Gonzalez HE, Gujrati M, Frederick M, Henderson Y, Arumugam J, Spring PW, Mitsudo K, Kim HW, Clayman GL.
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):754-9.
Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
Yoo GH, Piechocki MP, Ensley JF, Nguyen T, Oliver J, Meng H, Kewson D, Shibuya TY, Lonardo F, Tainsky MA.
Clin Cancer Res. 2002 Dec;8(12):3910-21.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on